Fresenius 4Q Profit Rose; Sets 2022 Guidance
2022年2月22日 - 4:01PM
Dow Jones News
By Giulia Petroni
Fresenius SE & Co. KGaA on Tuesday said profit rose in the
fourth quarter of last year and set guidance for 2022.
The German healthcare company reported a quarterly net profit
before special items of 521 million euros ($590.8 million), from
EUR494 million in the previous-year period.
Sales grew 5% on year at constant currency to EUR9.97 billion,
it said.
Looking at the current year, Fresenius said it expects sales
growth in a mid-single-digit percentage range, while net profit is
expected to grow in a low-single-digit percentage range. Both
projections are at constant currency.
The company said it expects Covid-19 to continue affecting
operations, but cases should decline from the spring onward.
Headwinds from cost inflation are reflected, though the company
said it doesn't see a significant acceleration of inflation effects
and supply challenges.
Fresenius confirmed its growth targets for the 2020-23 period,
saying it anticipates organic sales growth to reach the bottom to
the middle of the targeted 4% to 7% compounded annual growth rate.
Organic net profit growth is expected at the bottom end of the 5%
to 9% CAGR during 2020-23, it said.
The company said it will propose a dividend increase of 5% on
year to EUR0.92 a share for 2021.
Write to Giulia Petroni at giulia.petroni@wsj.com
(END) Dow Jones Newswires
February 22, 2022 01:46 ET (06:46 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Fresenius SE and Company... (PK) (USOTC:FSNUY)
過去 株価チャート
から 5 2024 まで 6 2024
Fresenius SE and Company... (PK) (USOTC:FSNUY)
過去 株価チャート
から 6 2023 まで 6 2024
Real-Time news about Fresenius SE and Company KGaA (PK) (その他OTC): 0 recent articles
その他のFresenius SE and Company KGaA (PK)ニュース記事